The European Commission (EC) has launched a public consultation on four revised chapters of its good manufacturing practice guidelines, saying a number of changes were necessary to reflect best ...
Key market opportunities include enhancing quality systems in the pharmaceutical supply chain, robust implementation of Good Distribution Practice (GDP), and combating counterfeit drug threats.
Clause 31 of the recently passed National Drug and Health Products Authority bill 2025 provides that : "A person licensed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results